Predictive Oncology (POAI) Form 3: CIO reports no holdings

Predictive Oncology (POAI) filed a Form 3 initial statement of beneficial ownership.

Rhea-AI Filing Summary

Predictive Oncology (POAI) filed a Form 3 initial statement of beneficial ownership. The reporting person serves as Chief Investment Officer and indicated no securities are beneficially owned as of the event date 10/08/2025.

The filing includes Exhibit 24.1, a Power of Attorney, and was submitted as a single‑person filing.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Predictive Oncology (POAI) file?

A Form 3 initial statement of beneficial ownership.

Who is the reporting person in POAI’s Form 3?

An officer serving as Chief Investment Officer.

What holdings were reported on the Form 3 for POAI?

No securities are beneficially owned.

What is the event date on POAI’s Form 3?

The event date is 10/08/2025.

Is the POAI Form 3 a joint filing?

No. It was filed by one reporting person.

Does the filing include a Power of Attorney?

Yes. Exhibit 24.1 Power of Attorney is included.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/17/2025 - 05:01 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

McLaughlin Thomas Louis

(Last) (First) (Middle)

C/O PREDICTIVE ONCOLOGY INC.

91 43RD STREET, SUITE 110

(Street)

PITTSBURGH PA 15201

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
10/08/2025

3. Issuer Name and Ticker or Trading Symbol
Predictive Oncology Inc. [ POAI ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Investment Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24.1 Power of Attorney filed herewith.

No securities are beneficially owned.

	/s/ Josh Blacher, Attorney-in-Fact	10/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.